Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Medicine
Published in: BMC Medicine 1/2011

Open Access 01-12-2011 | Research article

A systematic review on the effect of sweeteners on glycemic response and clinically relevant outcomes

Authors: Natasha Wiebe, Raj Padwal, Catherine Field, Seth Marks, Rene Jacobs, Marcello Tonelli

Published in: BMC Medicine | Issue 1/2011

Login to get access

Abstract

Background

The major metabolic complications of obesity and type 2 diabetes may be prevented and managed with dietary modification. The use of sweeteners that provide little or no calories may help to achieve this objective.

Methods

We did a systematic review and network meta-analysis of the comparative effectiveness of sweetener additives using Bayesian techniques. MEDLINE, EMBASE, CENTRAL and CAB Global were searched to January 2011. Randomized trials comparing sweeteners in obese, diabetic, and healthy populations were selected. Outcomes of interest included weight change, energy intake, lipids, glycated hemoglobin, markers of insulin resistance and glycemic response. Evidence-based items potentially indicating risk of bias were assessed.

Results

Of 3,666 citations, we identified 53 eligible randomized controlled trials with 1,126 participants. In diabetic participants, fructose reduced 2-hour blood glucose concentrations by 4.81 mmol/L (95% CI 3.29, 6.34) compared to glucose. Two-hour blood glucose concentration data comparing hypocaloric sweeteners to sucrose or high fructose corn syrup were inconclusive. Based on two ≤10-week trials, we found that non-caloric sweeteners reduced energy intake compared to the sucrose groups by approximately 250-500 kcal/day (95% CI 153, 806). One trial found that participants in the non-caloric sweetener group had a decrease in body mass index compared to an increase in body mass index in the sucrose group (-0.40 vs 0.50 kg/m2, and -1.00 vs 1.60 kg/m2, respectively). No randomized controlled trials showed that high fructose corn syrup or fructose increased levels of cholesterol relative to other sweeteners.

Conclusions

Considering the public health importance of obesity and its consequences; the clearly relevant role of diet in the pathogenesis and maintenance of obesity; and the billions of dollars spent on non-caloric sweeteners, little high-quality clinical research has been done. Studies are needed to determine the role of hypocaloric sweeteners in a wider population health strategy to prevent, reduce and manage obesity and its consequences.
Appendix
Available only for authorised users
Literature
1.
Parker KJ: Alternatives to sugar. The search for an ideal non-nutritive sweetener is almost a century old. Nature. 1978, 271: 493-495.CrossRefPubMed
2.
3.
4.
Lipson E: Chapter 1: Executive Summary. Trends in the US market for sugar, sugar substitutes, and sweeteners. Edited by: Packaged Facts. 2008, 1-26.
5.
Freedonia: Freedonia focus on food and beverage additives. 2010, The Freedonia Group I
6.
Sievenpiper JL, Carleton AJ, Chatha S, Jiang HY, de Souza RJ, Beyene J, Kendall CW, Jenkins DJ: Heterogeneous effects of fructose on blood lipids in individuals with type 2 diabetes: systematic review and meta-analysis of experimental trials in humans. Diabetes Care. 2009, 32: 1930-1937.CrossRefPubMedPubMedCentral
7.
Vermunt SH, Pasman WJ, Schaafsma G, Kardinaal AF: Effects of sugar intake on body weight: a review. Obes Rev. 2003, 4: 91-99.CrossRefPubMed
8.
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001, 344: 1343-1350.CrossRefPubMed
9.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002, 346: 393-403.CrossRefPubMed
10.
Gougeon R, Spidel M, Lee K, Field CJ: Canadian Diabetes Association National Nutrition Committee Technical Review: Non-nutritive intense sweeteners in diabetes management. Canadian Journal of Diabetes. 2004, 28: 385-399.
11.
Moher D, Liberati A, Tetzlaff J, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009, 339: b2535.CrossRefPubMedPubMedCentral
12.
Jadad AR, Moore RA, Carrol D, Jenkinson C, Reynolds JM, Gavaghan DJ, McQuay HJ: Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Control Clin Trials. 1996, 17: 1-12.CrossRefPubMed
13.
Schulze KF, Chalmers I, Hayes RJ, Altman DG: Empirical evidence of bias. JAMA. 1995, 273: 408-412.CrossRef
14.
Cho MK, Bero LA: The quality of drug studies published in symposium proceedings. Ann Intern Med. 1996, 124: 485-489.CrossRefPubMed
15.
Wiebe N, Vandermeer B, Platt RW, Klassen TP, Moher D, Barrowman NJ: A systematic review identifies a lack of standardization in methods for handling missing variance data. J Clin Epidemiol. 2006, 59: 342-353.CrossRefPubMed
16.
17.
Renwick AG, Molinary SV: Sweet-taste receptors, low-energy sweeteners, glucose absorption and insulin release. Br J Nutr. 2010, 104: 1415-1420.CrossRefPubMed
18.
Borenstein M, Hedges LV, Higgins JPT, Rothstein HR: Chapter 16: Identifying and quantifying heterogeneity. Introduction to Meta-Analysis. 2009, Wiley, 123: 124.CrossRef
19.
Lu G, Ades AE: Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004, 23: 3105-3124.CrossRefPubMed
20.
21.
Dias S, Welton NJ, Caldwell DM, Ades AE: Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010, 29: 932-944.CrossRefPubMed
22.
Prat-Larquemin L, Oppert JM, Bellisle F, Guy-Grand B: Sweet taste of aspartame and sucrose: effects on diet-induced thermogenesis. Appetite. 2000, 34: 245-251.CrossRefPubMed
23.
Melchior JC, Rigaud D, Colas-Linhart N, Petiet A, Girard A, Apfelbaum M: Immunoreactive beta-endorphin increases after an aspartame chocolate drink in healthy human subjects. PhysiolBehav. 1991, 50: 941-944.
24.
Gonzalez-Ortiz M, Ramos-Zavala MG, Gonzalez-Lopez RC, Robles-Cervantes JA, Martinez-Abundis E, Gonzalez-Ortiz M, Ramos-Zavala MG, Gonzalez-Lopez RC, Robles-Cervantes JA, Martinez-Abundis E: Effect of 2 liquid nutritional supplements for diabetes patients on postprandial glucose, insulin secretion, and insulin sensitivity in healthy individuals. JPEN J Parenter Enteral Nutr. 2009, 33: 67-70.CrossRefPubMed
25.
Horwitz DL, McLane M, Kobe P: Response to single dose of aspartame or saccharin by NIDDM patients. Diabetes Care. 1988, 11: 230-234.CrossRefPubMed
26.
Nguyen NU, Dumoulin G, Henriet MT, Berthelay S, Regnard J: Carbohydrate metabolism and urinary excretion of calcium and oxalate after ingestion of polyol sweeteners. J Clin Endocrinol Metab. 1993, 77: 388-392.PubMed
27.
Hassinger W, Sauer G, Cordes U, Krause U, Beyer J, Baessler KH: The effects of equal caloric amounts of xylitol, sucrose and starch on insulin requirements and blood glucose levels in insulin-dependent diabetics. Diabetologia. 1981, 21: 37-40.CrossRefPubMed
28.
Rizkalla SW, Luo J, Wils D, Bruzzo F, Slama G: Glycaemic and insulinaemic responses to a new hydrogenated starch hydrolysate in healthy and type 2 diabetic subjects. Diabetes Metab. 2002, 28 (5): 385-390.PubMed
29.
Wheeler ML, Fineberg SE, Gibson R, Fineberg N: Metabolic response to oral challenge of hydrogenated starch hydrolysate versus glucose in diabetes.[see comment]. Diabetes Care. 1990, 13: 733-740.CrossRefPubMed
30.
Maki KC, Kanter M, Rains TM, Hess SP, Geohas J: Acute effects of low insulinemic sweeteners on postprandial insulin and glucose concentrations in obese men. Int J Food Sci Nutr. 2009, 60 (SUPPL 3): 48-55.CrossRefPubMed
31.
Teff KL, Grudziak J, Townsend RR, Dunn TN, Grant RW, Adams SH, Keim NL, Cummings BP, Stanhope KL, Havel PJ: Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses. J Clin Endocrinol Metab. 2009, 94: 1562-1569.CrossRefPubMedPubMedCentral
32.
Bowen J, Noakes M, Clifton PM: Appetite hormones and energy intake in obese men after consumption of fructose, glucose and whey protein beverages. Int J Obes. 2007, 31: 1696-1703.CrossRef
33.
Chong MF, Fielding BA, Frayn KN, Chong MFF, Fielding BA, Frayn KN: Mechanisms for the acute effect of fructose on postprandial lipemia. Am J Clin Nutr. 2007, 85: 1511-1520.PubMed
34.
Visvanathan R, Chen R, Garcia M, Horowitz M, Chapman I: The effects of drinks made from simple sugars on blood pressure in healthy older people.[see comment]. Br J Nutr. 2005, 93: 575-579.CrossRefPubMed
35.
Teff KL, Elliott SS, Tschop M, Kieffer TJ, Rader D, Heiman M, Townsend RR, Keim NL, D'Alessio D, Havel PJ: Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab. 2004, 89: 2963-2972.CrossRefPubMed
36.
Vozzo R, Baker B, Wittert GA, Wishart JM, Morris H, Horowitz M, Chapman I: Glycemic, hormone, and appetite responses to monosaccharide ingestion in patients with type 2 diabetes. Metabolism. 2002, 51: 949-957.CrossRefPubMed
37.
Spiller GA, Moynihan S, Butterfield G: Effects of sun-dried raisins on serum glucose: support for a convenient, plant-based snack food. Vegetarian Nutr. 1998, 2: 93-95.
38.
Stewart SL, Black RM, Wolever TMS, Anderson GH: The relationship between glycaemic response to breakfast cereals and subjective appetite and food intake. Nutr Res. 1997, 17: 1249-1260.CrossRef
39.
Blaak EE, Saris WHM: Postprandial thermogenesis and substrate utilization after ingestion of different dietary carbohydrates. Metabolism. 1996, 45: 1235-1242.CrossRefPubMed
40.
Fukagawa NK, Veirs H, Langeloh G: Acute effects of fructose and glucose ingestion with and without caffeine in young and old humans. Metabolism. 1995, 44: 630-638.CrossRefPubMed
41.
Schwarz JM, Schutz Y, Piolino V, Schneider H, Felber JP, Jequier E: Thermogenesis in obese women: effect of fructose vs. glucose added to a meal. Am J Physiol. 1992, 262: E394-E401.PubMed
42.
Bukar J, Mezitis NH, Saitas V, Pi-Sunyer FX: Frozen desserts and glycemic response in well-controlled NIDDM patients. Diabetes Care. 1990, 13: 382-385.CrossRefPubMed
43.
Georgakopoulos K, Katsilambros N, Fragaki M, Poulopoulou Z, Kimbouris J, Sfikakis P, Raptis S: Recovery from insulin-induced hypoglycemia after saccharose or glucose administration. Clin Physiol Biochem. 1990, 8: 267-272.PubMed
44.
Schwarz JM, Schutz Y, Froidevaux F, Acheson KJ, Jeanpretre N, Schneider H, Felber JP, Jequier E: Thermogenesis in men and women induced by fructose vs glucose added to a meal. Am J Clin Nutr. 1989, 49: 667-674.PubMed
45.
Simonson DC, Tappy L, Jequier E, Felber JP, DeFronzo RA: Normalization of carbohydrate-induced thermogenesis by fructose in insulin-resistant states. Am J Physiol. 1988, 254: E201-E207.PubMed
46.
Jansen RW, Penterman BJ, van Lier HJ, Hoefnagels WH: Blood pressure reduction after oral glucose loading and its relation to age, blood pressure and insulin. Am J Cardiol. 1987, 60: 1087-1091.CrossRefPubMed
47.
Tappy L, Randin JP, Felber JP, Chiolero R, Simonson DC, Jequier E, DeFronzo RA: Comparison of thermogenic effect of fructose and glucose in normal humans. Am J Physiol. 1986, 250: E718-724.PubMed
48.
Samanta A, Burden AC, Jones GR: Plasma glucose responses to glucose, sucrose, and honey in patients with diabetes mellitus: an analysis of glycaemic and peak incremental indices. Diabet Med. 1985, 2: 371-373.CrossRefPubMed
49.
Bantle JP, Laine DC, Castle GW, Thomas JW, Hoogwerf BJ, Goetz FC: Postprandial glucose and insulin responses to meals containing different carbohydrates in normal and diabetic subjects. N Engl J Med. 1983, 309: 7-12.CrossRefPubMed
50.
Crapo PA, Scarlett JA, Kolterman OG: Comparison of the metabolic responses to fructose and sucrose sweetened foods. Am J Clin Nutr. 1982, 36: 256-261.PubMed
51.
Mann JI, Truswell AS, Pimstone BL: The different effects of oral sucrose and glucose on alimentary lipaemia. Clin Sci. 1971, 41: 123-129.CrossRefPubMed
52.
Van Can JGP, Ijzerman TH, Van Loon LJC, Brouns F, Blaak EE: Reduced glycaemic and insulinaemic responses following isomaltulose ingestion: Implications for postprandial substrate use. Br J Nutr. 2009, 102: 1408-1413.CrossRefPubMed
53.
Qin LQ, Li J, Wang Y, Wang PY, Sato A, Kaneko T: Effect of repeated intake of disaccharides on glucose metabolism and insulin secretion in healthy adults - Comparison between sucrose and maltose. J Health Sci. 2003, 49: 226-228.CrossRef
54.
Stanhope KL, Griffen SC, Bair BR, Swarbrick MM, Keim NL, Havel PJ: Twenty-four-hour endocrine and metabolic profiles following consumption of high-fructose corn syrup-, sucrose-, fructose-, and glucose-sweetened beverages with meals. Am J Clin Nutr. 2008, 87: 1194-1203.PubMedPubMedCentral
55.
Melanson KJ, Zukley L, Lowndes J, Nguyen V, Angelopoulos TJ, Rippe JM: Effects of high-fructose corn syrup and sucrose consumption on circulating glucose, insulin, leptin, and ghrelin and on appetite in normal-weight women. Nutrition. 2007, 23: 103-112.CrossRefPubMed
56.
Kawai K, Yoshikawa H, Murayama Y, Okuda Y, Yamashita K: Usefulness of palatinose as a caloric sweetener for diabetic patients. Horm Metab Res. 1989, 21: 338-340.CrossRefPubMed
57.
Erkelens DW, Stofkooper A, Van DBE, Van D: Glycaemic effect of mono-, di- and polysaccharides in a mixed meal in diabetic patients. Neth J Med. 1985, 28: 157-163.PubMed
58.
Grysman A, Carlson T, Wolever TM, Wolever TMS: Effects of sucromalt on postprandial responses in human subjects. Eur J Clin Nutr. 2008, 62: 1364-1371.CrossRefPubMed
59.
Munstedt K, Sheybani B, Hauenschild A, Bruggmann D, Bretzel RG, Winter D: Effects of basswood honey, honey-comparable glucose-fructose solution, and oral glucose tolerance test solution on serum insulin, glucose, and C-peptide concentrations in healthy subjects. J Med Food. 2008, 11: 424-428.CrossRefPubMed
60.
Bowker SL, Majumdar SR, Johnson JA: Systematic review of indicators and measurements used in controlled studies of quality improvement for type 2 diabetes. Can J Diabetes. 2005, 29: 230-238.
61.
Reid M, Hammersley R, Hill AJ, Skidmore P: Long-term dietary compensation for added sugar: effects of supplementary sucrose drinks over a 4-week period. Br J Nutr. 2007, 97: 193-203.CrossRefPubMed
62.
Chantelau EA, Gosseringer G, Sonnenberg GE, Berger M: Moderate intake of sucrose does not impair metabolic control in pump-treated diabetic out-patients. Diabetologia. 1985, 28: 204-207.CrossRefPubMed
63.
Raben A, Vasilaras TH, Moller AC, Astrup A: Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am J Clin Nutr. 2002, 76: 721-729.PubMed
64.
Ngo Sock ET, Le KA, Ith M, Kreis R, Boesch C, Tappy L: Effects of a short-term overfeeding with fructose or glucose in healthy young males. Br J Nutr. 2010, 103: 939-943.CrossRefPubMed
65.
Bantle JP, Raatz SK, Thomas W, Georgopoulos A: Effects of dietary fructose on plasma lipids in healthy subjects. Am J Clin Nutr. 2000, 72: 1128-1134.PubMed
66.
Macdonald I, Taylor J: Differences in body weight loss on diets containing either sucrose or glucose syrup. Guys Hosp Rep. 1973, 122: 155-159.PubMed
67.
Bantle JP, Laine DC, Thomas JW: Metabolic effects of dietary fructose and sucrose in types I and II diabetic subjects. JAMA. 1986, 256: 3241-3246.CrossRefPubMed
68.
Okuno M, Kim MK, Mizu M, Mori M, Mori H, Yamori Y: Palatinose-blended sugar compared with sucrose: different effects on insulin sensitivity after 12 weeks supplementation in sedentary adults. Int J Food Sci Nutr. 2010, 61: 643-651.CrossRefPubMed
69.
Yaghoobi N, Al-Waili N, Ghayour-Mobarhan M, Parizadeh SM, Abasalti Z, Yaghoobi Z, Yaghoobi F, Esmaeili H, Kazemi-Bajestani SM, Aghasizadeh R, Saloom KY, Ferns GA: Natural honey and cardiovascular risk factors; effects on blood glucose, cholesterol, triacylglycerole, CRP, and body weight compared with sucrose. ScientificWorldJournal. 2008, 8: 463-469.CrossRefPubMed
70.
Boesch C, Ith M, Jung B, Bruegger K, Erban S, Diamantis I, Kreis R, Bar A: Effect of oral D-tagatose on liver volume and hepatic glycogen accumulation in healthy male volunteers. Regul Toxicol Pharmacol. 2001, 33: 257-267.CrossRefPubMed
71.
Luo J, Van Yperselle M, Rizkalla SW, Rossi F, Bornet FR, Slama G: Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics. J Nutr. 2000, 130: 1572-1577.PubMed
72.
Luo J, Rizkalla SW, Alamowitch C, Boussairi A, Blayo A, Barry JL, Laffitte A, Guyon F, Bornet FR, Slama G: Chronic consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism. Am j clin nutr. 1996, 63: 939-945.PubMed
73.
Alles MS, de Roos NM, Bakx JC, van de Lisdonk E, Zock PL, Hautvast GA: Consumption of fructooligosaccharides does not favorably affect blood glucose and serum lipid concentrations in patients with type 2 diabetes. Am J Clin Nutr. 1999, 69: 64-69.PubMed
74.
Pearson ES: The application of statistical methods to industrial standardization and quality controls. 1960, London, UK: B.S. 600, British Standards Institution
75.
Bellisle F, Drewnowski A: Intense sweeteners, energy intake and the control of body weight. Eur J Clin Nutr. 2007, 61: 691-700.CrossRefPubMed
76.
Smeets PA, de Graaf C, Stafleu A, van Osch MJ, van der Grond J: Functional magnetic resonance imaging of human hypothalamic responses to sweet taste and calories. Am J Clin Nutr. 2005, 82: 1011-1016.PubMed
77.
Tam J, Fukumura D, Jain RK: A mathematical model of murine metabolic regulation by leptin: energy balance and defense of a stable body weight. Cell Metab. 2009, 9: 52-63.CrossRefPubMedPubMedCentral
78.
Sullivan EL, Cameron JL: A rapidly occurring compensatory decrease in physical activity counteracts diet-induced weight loss in female monkeys. Am J Physiol Regul Integr Comp Physiol. 2010, 298: R1068-1074.CrossRefPubMedPubMedCentral
79.
Erlanson-Albertsson C: How palatable food disrupts appetite regulation. Basic Clin Pharamcol Toxicol. 2005, 97: 61-73.CrossRef
80.
Black RM, Leiter LA, Anderson GH: Consuming aspartame with and without taste: differential effects on appetite and food intake of young adult males. Physiol Behav. 1993, 53: 459-466.CrossRefPubMed
81.
Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K: Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004, 292: 1724-1737.CrossRefPubMed
82.
Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH: The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009, 9: 88.CrossRefPubMedPubMedCentral
83.
Gougeon R, Spidel M, Lee K, Field CJ: Canadian Diabetes Association National Nutrition Committee Technical Review: Non-nutritive Intense Sweeteners in Diabetes Management. Can J Diabetes. 2004, 28: 385-399.
84.
Wolever T, Barbeau M, Charron S, Harrigan K, Leung S, Madrick B, Taillefer T, Seto C: Guidelines for the nutritional management of diabetes mellitus in the new millennium: A position statement by the Canadian Diabetes Association. Can J Diabetes Care. 1999, 23: 56-69.
85.
86.
87.
88.
89.
90.
91.
92.
Metadata
Title
A systematic review on the effect of sweeteners on glycemic response and clinically relevant outcomes
Authors
Natasha Wiebe
Raj Padwal
Catherine Field
Seth Marks
Rene Jacobs
Marcello Tonelli
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2011
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/1741-7015-9-123

Other articles of this Issue 1/2011

BMC Medicine 1/2011 Go to the issue

Research article

Even low level of physical activity is associated with reduced mortality among people with metabolic syndrome, a population based study (the HUNT 2 study, Norway)

Commentary

Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment

Research article

Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting

Minireview

Circulating tumor cells in breast cancer: A tool whose time has come of age

Research article

A functional tandem-repeats polymorphism in the downstream of TERTis associated with the risk of nasopharyngeal carcinoma in Chinese population

Review

The epidemic of sexually transmitted infections in China: implications for control and future perspectives